Streetbeat News

Regulatory

NVAX

Novavax shares declined after the FDA excluded the company from its latest updates on emergency use authorization for vaccines.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 7:03 pm

SCHW

TD

Charles Schwab shares are declining after TD Bank sold 40.50 million shares, reducing its stake from 12.3% to 10.1%. This sale is linked to TD Bank's anticipation of penalties from U.S. regulatory probes related to anti-money laundering deficiencies.

Portfolio Pulse from Dylan Berman

August 22, 2024 | 6:48 pm

TSLA

Tesla shares are declining following the announcement of a delay in the Cybertruck's full self-driving rollout and an investigation by the National Transportation Safety Board into a Tesla vehicle crash.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 6:42 pm

BNTX

MRNA

NVAX

PFE

The FDA has approved updated COVID-19 vaccines from Pfizer/BioNTech and Moderna, targeting the Omicron variant KP.2 strain. Novavax's vaccine was not included in this approval. The updated vaccines are expected to be available soon, with Pfizer and Moderna stocks experiencing a decline following the news.

Portfolio Pulse from Vandana Singh

August 22, 2024 | 6:33 pm

NUWE

Nuwellis has filed a new patent application for an 'Extracorporeal Blood Filtering Machine and Methods for Renal Replacement Therapy'. This development could enhance their product offerings in the medical device sector.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 6:30 pm

AMZN

DIS

NFLX

SONY

The $8.5 billion merger between Walt Disney Co. and India's Reliance Industries media assets faces antitrust concerns from the Indian regulator over cricket broadcasting rights. The companies are exploring remedies but are reluctant to part with these rights, which are crucial for the merger's success.

Portfolio Pulse from Vandana Singh

August 22, 2024 | 6:16 pm

NVAX

Novavax is collaborating with the U.S. FDA to secure authorization for its 2024-2025 formula Covid-19 vaccine. The company anticipates receiving approval in time for the peak vaccination season.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 6:04 pm

BTCUSD

Jerome Powell is expected to signal a shift towards easing monetary policy at the Jackson Hole Economic Symposium, with a 25 basis point rate cut anticipated in September. This has kept U.S. financial markets buoyant, but Bitcoin remains below its all-time high despite positive crypto developments.

Portfolio Pulse from Murtuza Merchant

August 22, 2024 | 5:58 pm

BIIB

Biogen's Alzheimer's drug, Leqembi, has been approved by the UK's Medicines and Healthcare products Regulatory Agency. However, the National Institute for Health and Care Excellence (NICE) does not recommend it for NHS reimbursement due to cost-effectiveness concerns. Despite showing a small benefit in slowing disease progression, the drug's high costs and limited long-term evidence are barriers.

Portfolio Pulse from Vandana Singh

August 22, 2024 | 5:45 pm